{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Corteva, Inc.
Is Corteva, Inc. overvalued or undervalued?
As of November 7, 2025, Corteva, Inc. is fairly valued with a P/E ratio of 37, a Price to Book Value of 2.01, and an EV to EBITDA of 14.55, outperforming the S&P 500 recently but lagging in longer-term returns compared to peers in the Chemicals & Petrochemicals industry.
Corteva Opens Weak with 3.04% Gap Down Amid Market Concerns
Corteva, Inc. opened with a notable loss, reflecting a broader trend in its stock performance. The company has a market capitalization of approximately USD 49,540 million and a P/E ratio of 37.00. It features a high dividend yield and a low debt-to-equity ratio, indicating financial stability.
Corteva's Valuation Shift Raises Concerns Amid Strong Financial Performance Metrics
Corteva, Inc. has recently experienced a change in its evaluation, reflecting a shift in its valuation grade. Key financial metrics, including a P/E ratio of 37 and a robust operating profit growth rate of 24.77%, underscore the company's strong performance despite its premium valuation.
Is Corteva, Inc. overvalued or undervalued?
As of October 17, 2025, Corteva, Inc. is considered overvalued with a valuation grade of very expensive, reflected in its high P/E ratio of 37 and underperformance compared to the S&P 500, which raises concerns about its growth prospects.
Is Corteva, Inc. overvalued or undervalued?
As of October 17, 2025, Corteva, Inc. is considered very expensive due to its high P/E ratio of 37, PEG ratio of 2.48, and EV to EBITDA ratio of 14.55, all of which exceed industry peers, while its stock has underperformed the S&P 500 over the past year.
Is Corteva, Inc. overvalued or undervalued?
As of October 17, 2025, Corteva, Inc. is considered very expensive due to high valuation metrics and underperformance compared to the S&P 500, with a P/E ratio of 37 and a 1-month return of -13.08%.
Corteva Stock Hits Day Low of $65.91 Amid Price Pressure
Corteva, Inc. faced a decline in its stock price today, marking a challenging market day. Despite recent fluctuations, the company has shown resilience over the past year with a notable return. Corteva maintains a strong market position, healthy operating profit growth, and high institutional holdings.
Is Corteva, Inc. overvalued or undervalued?
As of August 6, 2025, Corteva, Inc. is considered very expensive and overvalued, with a P/E ratio of 37 and an EV to EBITDA of 14.55, both exceeding industry averages, despite a strong long-term return of 143.74% that has recently declined.
Corteva Stock Hits Day Low of $69.28 Amid Price Pressure
Corteva, Inc. saw a significant stock price decline on September 15, 2025, amid broader market trends. Despite recent pressures, the company has demonstrated strong year-to-date performance and solid financial metrics, including a low debt-to-equity ratio and impressive operating profit growth, highlighting its operational strength.
Is Corteva, Inc. overvalued or undervalued?
As of May 7, 2025, Corteva, Inc. is considered overvalued with a valuation grade of "expensive," reflected by a P/E ratio of 37, an EV to EBITDA of 14.55, and a PEG ratio of 2.48, despite outperforming the S&P 500 with a 40.67% return over the past year.
Is Corteva, Inc. technically bullish or bearish?
As of May 8, 2025, Corteva, Inc. exhibits a bullish technical trend supported by strong indicators like MACD, Bollinger Bands, and moving averages, while significantly outperforming the S&P 500 year-to-date and over the last year.
Who are in the management team of Corteva, Inc.?
As of March 2022, the management team of Corteva, Inc. includes Gregory Page (Independent Chairman), James Collins (CEO), and several Independent Directors: Lamberto Andreotti, Robert Brown, Klaus Engel, Michael Johanns, and Lois Juliber. They guide the company's strategic direction.
What does Corteva, Inc. do?
Corteva, Inc. is a large-cap provider of agricultural products in the Chemicals & Petrochemicals industry, with recent net sales of $4.42 billion and a net profit of $667 million. Key metrics include a P/E ratio of 37.00 and a dividend yield of 95.34%.
How big is Corteva, Inc.?
As of Jun 18, Corteva, Inc. has a market capitalization of $50.62 billion, with recent net sales of $16.83 billion and a net profit of $1.15 billion.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
